BioInnovation adds eight early-stage companies to acceleration programme
Therapeutic: olutasidenib for acute myeloid leukaemia
Data shows insulin icodec meets additional endpoints in adults with type 2 diabetes in phase 3a trials
Novo invests $40m in proteomics technology company
Novo enters research partnership with Flagship Pioneering
Novo Nordisk and MIT extend oral delivery tech collaboration
Novo companies announce enzyme collaboration for biopharmaceuticals
Novo Nordisk plans $117m API manufacturing expansion
Novo Nordisk donates $40m wastewater pre-treatment facility
Novo Nordisk funds $27m global biomanufacturing programme
Purdue Pharma sells North Carolina site to Novo Nordisk
Novo Nordisk expands Danish production facilities
Novo Nordisk Pharmatech A/S signs Asia Pacific distribution agreement
with DKSH
Bristol diabetes spin-out company acquired by Novo Nordisk
Novo Nordisk enters a distribution agreement with Signet Chemical
